Evidence map›Paper›PMID 30309004›Full record

ReviewBiology2018

Selectable Markers and Reporter Genes for Engineering the Chloroplast of

Lola Esland, Marco Larrea-Alvarez, Saul Purton

Open access · goldAbstract readReview
In one paragraph

Review in Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. The Chloroplast ofInternational journal of molecular sciences · 2021
    Review
  15. Review
  16. PeerJ · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Lola EslandDepartment of Life Sciences, Imperial College London, South Kensington Campus, London SW7 2AZ, UK. l.esland17@imperial.ac.uk.
Marco Larrea-AlvarezSchool of Biological Sciences and Engineering, Yachay-Tech University, Hacienda San José, Urcuquí-Imbabura 100650, Ecuador. malarrea@yachaytech.edu.ec.
Saul PurtonInstitute of Structural & Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK. s.purton@ucl.ac.uk.ORCID 0000-0002-9342-1773
Imperial College London · GBInstitute of Structural and Molecular Biology · GBUniversidad Yachay Tech · EC

Funding

Biotechnology and Biological Sciences Research Council BB/F016948/1Biotechnology and Biological Sciences Research Council BB/L002957/1Biotechnology and Biological Sciences Research Council BB/L013789/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chlamydomonas reinhardtiichloroplast engineeringreporter genesselectable markers

Identifiers

PMID30309004
PMCPMC6315944
OpenAlexW2896112789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.